HomeCompareLGGNF vs PFE

LGGNF vs PFE: Dividend Comparison 2026

LGGNF yields 7.98% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PFE wins by $21.1K in total portfolio value· pulled ahead in Year 9
10 years
LGGNF
LGGNF
● Live price
7.98%
Share price
$3.58
Annual div
$0.29
5Y div CAGR
-8.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$28.4K
Annual income
$476.76
Full LGGNF calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — LGGNF vs PFE

📍 PFE pulled ahead of the other in Year 9

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLGGNFPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LGGNF + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
LGGNF pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LGGNF
Annual income on $10K today (after 15% tax)
$678.48/yr
After 10yr DRIP, annual income (after tax)
$405.25/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, PFE beats the other by $21,914.66/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LGGNF + PFE for your $10,000?

LGGNF: 50%PFE: 50%
100% PFE50/50100% LGGNF
Portfolio after 10yr
$39.0K
Annual income
$13,367.74/yr
Blended yield
34.28%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

LGGNF
No analyst data
Altman Z
0.2
Piotroski
7/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LGGNF buys
0
PFE buys
0
No recent congressional trades found for LGGNF or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLGGNFPFE
Forward yield7.98%6.13%
Annual dividend / share$0.29$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-8.3%13.2%
Portfolio after 10y$28.4K$49.6K
Annual income after 10y$476.76$26,258.71
Total dividends collected$6.2K$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: LGGNF vs PFE ($10,000, DRIP)

YearLGGNF PortfolioLGGNF Income/yrPFE PortfolioPFE Income/yrGap
1$11,432$731.96$9,153$693.39+$2.3KLGGNF
2$12,949$717.13$8,593$849.25+$4.4KLGGNF
3$14,552$696.16$8,336$1,066.78+$6.2KLGGNF
4$16,241$670.45$8,437$1,384.80+$7.8KLGGNF
5$18,019$641.28$9,013$1,875.40+$9.0KLGGNF
6$19,890$609.75$10,306$2,680.72+$9.6KLGGNF
7$21,859$576.82$12,820$4,101.38+$9.0KLGGNF
8$23,933$543.28$17,673$6,826.70+$6.3KLGGNF
9← crossover$26,118$509.76$27,543$12,591.86$1.4KPFE
10$28,423$476.76$49,560$26,258.71$21.1KPFE

LGGNF vs PFE: Complete Analysis 2026

LGGNFStock

Legal & General Group Plc provides various insurance products and services in the United Kingdom, the United States, and internationally. It operates in four segments: Legal & General Retirement (LGR), Legal & General Investment Management (LGIM), Legal & General Capital (LGC), and Legal & General Insurance (LGI). The LGR segment offers annuity contracts with guaranteed income for a specified time; longevity insurance products; lifetime mortgages; lifetime care plans; retirement interest only mortgages; and workplace savings scheme that provides corporate pension scheme solutions. The LGIM segment offers index fund management; active fixed income funds and liquidity funds; active equity management; solution and liability driven investment; multi-asset funds; corporate pension scheme solutions; and real assets. The LGC segment provides investment strategy and implementation, and direct investment and structuring services. The LGI segment offers protection products, such as health, disability, critical illness, and accident; individual term assurance; reinsurance; savings and death benefits; and annuities. It is also involved in the unit trust and institutional fund management, mortgage finance, treasury, building project and modular housing development, general insurance, and open-ended investment businesses. In addition, the company engages in the investment, operation, management, trading, and letting and operation of leased real estate; and construction of commercial buildings, financial intermediation, pension tracing and transfer, insurance agents and brokers, fund general partner, commercial lending, venture capital investing, contractual scheme, investor alternative investment fund, collective asset-management, and investment management activities; and provision of investment advisory, business information consultancy, and technology services. Legal & General Group Plc was founded in 1836 and is headquartered in London, the United Kingdom.

Full LGGNF Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this LGGNF vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LGGNF vs SCHDLGGNF vs JEPILGGNF vs OLGGNF vs KOLGGNF vs MAINLGGNF vs JNJLGGNF vs MRKLGGNF vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.